EVALUATION OF ACROMEGALY BY RADIOIMMUNOASSAY OF SOMATOMEDIN-C
EVALUATION OF ACROMEGALY BY RADIOIMMUNOASSAY OF SOMATOMEDIN-C
复制标题
DOI:
10.1056/nejm197911223012102
复制
发表时间:
1979-01-01
影响因子:
158.5
通讯作者:
UNDERWOOD, LE
中科院分区:
文献类型:
--
作者:
CLEMMONS, DR;VANWYK, JJ;UNDERWOOD, LE
Serum concentrations of somatomedin-C [SM-C] were measured by radioimmunoassay in 57 acromegalic patients and compared with various indicators of disease activity. The mean fasting SM-C concentration was 6.8 U[units]/ml (range, 2.6-21.7) for the acromegalics and 0.67 U/ml (range, 0.31-1.4) for 48 normal, fasting adults. The SM-C concentration correlated significantly with: heel-pad thickness (r [correlation coefficient] = 0.73), fasting glucose (r = 0.74), and 1 h postprandial glucose (r = 0.77). In contrast, glucose-suppressed growth hormone [GH] correlated weakly (r = 0.34, 0.36, 0.34) with these clinical indexes of severity. Fasting GH levels showed no correlation (r = 0.14). Five active acromegalics had normal GH levels after glucose suppression, but they had elevated SM-C. In 15 patients studied 1 yr after treatment, changes in SM-C concentrations paralleled the degree of clinical improvement. Measurement of SM-C appears to provide a reliable means for confirming the diagnosis of acromegaly and of clinical disease activity than measurement of GH concentrations.